Both sexes should be treated equally: sex difference in patients with ischemic heart failure undergoing surgical revascularization

We read with the interest the work of Piña et al. (1). STICH trial (2) is the first and for long time remains only randomized trial to compare CABG plus medical therapy for heart failure (HF) versus medical therapy for HF only in patients with severe left ventricular dysfunction (EF ≤35%, for inclusion criteria see below).